Answer:
This phenomenon is known by neuroscientists as Neuroplasticity, or brain plasticity
Explanation:
Think of plasticity, Neuroplasticity, or brain plasticity, is the simplest terms, as the ability of parts of the brain to adapt their function or ability to change throughout life.
Structural plasticity - brains ability to change in response to the environment.
Functional plasticity-brains ability to change in response to the activities.
The inputs are glucose and oxygen and the outputs are water and carbon dioxide.
Short Answer: The amygdala is located in the brain and its functions are related to emotional learning.
Explanation
The amygdala is a brain structure located in the temporal lobe of the brain. Its functions are related to the emotional system of the brain, and memory. In addition, the amygdala has been shown to influence the emotional learning process. The amygdala is mainly responsible for the formation and storage of memories associated with emotional events, so external sensory stimuli reach the basolateral group of the amygdala, where associations are formed with memories of the stimulus (mainly related to fear).
Sex linked inheritance usually occurs on the X chromosome. Males have one X, meaning if they receive the specific sex linked gene, they will have the trait. However for a female to possess the trait, she must receive 2 X chromosomes for that trait.
Answer:
Explanation:
The more similar the two species are, the more their niche overlaps and the more competition there is.
<em>The most interesting results obtained in animal models of passive immunotherapies developed according to the “amyloid-beta cascade hypothesis” and the “Tau hypothesis” are monoclonal antibodies that directly or indirectly target Aβ plaques or neurofibrillary tangles. Unfortunately, these therapeutic antibodies cannot replicate their promising effects on humans at the clinical phase. Despite this, we still hope to learn from these failures and to explore new pathways. The great effects obtained in animals with passive immunotherapy suggest that this technology may be an important key to curative treatment. The remaining challenge is to find a way to achieve the same encouraging results for humans. Alzheimacy expects to join hands with global partners to focus on the development of therapeutic antibodies for Alzheimer’s disease (AD) and continue to fight against this disease.</em>
<em>https://www.creativebiomart.net/alzheimacy/therapeutics/therapeutic-antibody/</em>